About Brawn Biotech Limited
Data last updated: 23 December 2025
Brawn Biotech Limited is a public limited company based in Delhi, Delhi, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 07 November 1985, the company has been in operation for over 41 years.
Registered with ROC Delhi under CIN L74899DL1985PLC022468. Listed on BSE: 530207.
Capital: an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹3 Cr. Formerly known as Brawn Pharmaceuticals Limited and Brawn Pharmaceuticals Private Limited. It is led by directors including Brij Raj Gupta and Brij Bala Gupta.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: First Floor C – 64 Lagpat Nagar – 1, Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.56 Cr, a decline of 18% compared to the previous year.
The company is associated with 2 brands - Brawnpharma, Brawn Biotech. As per MCA filings, the company has satisfied charges of ₹30.28 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brawnbiotech.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressFirst Floor C – 64 Lagpat Nagar – 1, Delhi, Delhi, India – 110024
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Brawn Biotech Limited
Brawn Biotech Limited has undergone 4 name changes throughout its history. The current legal name is Brawn Biotech Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Brawn Biotech Limited | Current |
| Brawn Pharmaceuticals Limited | Previous |
| Brawn Pharmaceuticals Private Limited | Previous |
| Brawn Pharmaceuticals Ltd | Previous |
| Brawn Pharmaceuticals P Ltd | Previous |
Associated Brands with Brawn Biotech Limited
Brawn Biotech Limited operates two associated brands: Brawnpharma and Brawn Biotech. These brands represent Brawn Biotech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations are distributed across major healthcare segments. | brawnbiotech.com | |
| Pharmaceutical products are developed and distributed by Brawnpharma. | brawnpharma.com |
Competitors & Alternatives of Brawn Biotech Limited
Brands and companies operating in the same space as Brawn Biotech Limited include Entero Healthcare, AmerisourceBergen, Keimed and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
India's leading healthcare products distribution platform | Mumbai, India, India | 2018 |
|
|
Pharmaceutical distribution and supply chain services are provided globally. | Chesterbrook, United States, United States | 1985 |
|
|
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | Hyderabad, India, India | 2000 |
|
|
Provider of medical equipment, devices, and drugs distribution services | Hyderabad, India, India | 1995 |
|
|
Distributor of pharmaceutical raw materials | Ahmedabad, India, India | 2011 |
|
|
Serves as a distributor of a wide range of pharmaceutical drugs. | Bengaluru, India, India | 2016 |
|
|
A healthcare company specializing in multidisciplinary engineering and technical services. | Patna, India, India | 2009 |
|
|
Distributes pharmaceuticals to over 1500 retailers and wholesalers in Kolkata. | Kolkata, India, India | 1970 |
Business Activity of Brawn Biotech Limited
Brawn Biotech Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Auditor Details of Brawn Biotech Limited
Brawn Biotech Limited is audited by RAJIV UDAY & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| RAJIV UDAY & ASSOCIATES (ICAI peer reviewed, certificate valid till 2027-05-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Brawn Biotech Limited
Brawn Biotech Limited is currently managed by 6 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Raj Gupta | Director | 07 Nov 1985 | 40 Years 8 Months | Current |
| Brij Bala Gupta | Director | 24 Nov 2004 | 21 Years 7 Months | Current |
| Mayank Jain | Director | 27 Aug 2024 | 1 Years 10 Months | Current |
|
Pooja Jha
Also directs:
Brawn Laboratories Limited
|
Director | 27 Aug 2024 | 1 Years 10 Months | Current |
Financials of Brawn Biotech Limited FY 2026 filings available
Brawn Biotech Limited reported revenue of ₹16.98 Cr (up 26.09% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹16.98 Cr | ₹13.47 Cr | ₹16.49 Cr | ₹22.23 Cr | ₹8.62 Cr | ₹34.98 Cr | ₹49.62 Cr | ₹65.18 Cr |
| Other Income | ₹45.4 Lakh | ₹9.33 Lakh | ₹8.81 Lakh | ₹92,000 | ₹37,000 | ₹30.93 Lakh | ₹17.09 Lakh | ₹73.78 Lakh |
| Total Income | ₹17.43 Cr | ₹13.56 Cr | ₹16.58 Cr | ₹22.24 Cr | ₹8.62 Cr | ₹35.28 Cr | ₹49.79 Cr | ₹65.92 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.64 Cr | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹14.11 Cr | ₹16.38 Cr | ₹15.59 Cr | ₹19.24 Cr | ₹11.05 Cr | ₹28.25 Cr | ₹42.15 Cr | ₹58.49 Cr |
| Changes in Inventories | ₹40.49 Lakh | -₹4.45 Cr | -₹1.23 Cr | -₹6.77 Lakh | -₹4.47 Cr | ₹13.2 Lakh | -₹5.02 Lakh | ₹90,000 |
| Employee Benefit Expense | ₹68.36 Lakh | ₹1.13 Cr | ₹1.4 Cr | ₹1.4 Cr | ₹1.8 Cr | ₹2.36 Cr | ₹3.08 Cr | ₹3.02 Cr |
| Finance Costs | ₹45,000 | ₹37,000 | ₹38,000 | ₹82,000 | ₹6.25 Lakh | ₹3.69 Lakh | ₹4.94 Lakh | ₹6.14 Lakh |
| Depreciation & Amortisation | ₹12.2 Lakh | ₹11.46 Lakh | ₹9.94 Lakh | ₹10.91 Lakh | ₹5.33 Lakh | ₹3.35 Lakh | ₹3.47 Lakh | ₹3.2 Lakh |
| Other Expenses | ₹2.1 Cr | ₹2.18 Cr | ₹2.26 Cr | ₹1.96 Cr | ₹2.24 Cr | ₹3.19 Cr | ₹3.7 Cr | ₹2.5 Cr |
| Total Expenses | ₹17.43 Cr | ₹15.36 Cr | ₹18.13 Cr | ₹22.65 Cr | ₹10.74 Cr | ₹35.64 Cr | ₹48.97 Cr | ₹64.11 Cr |
| Profit Before Exceptional Items & Tax | ₹10,000 | -₹1.8 Cr | -₹1.54 Cr | -₹41.16 Lakh | -₹2.12 Cr | -₹35.99 Lakh | ₹81.98 Lakh | ₹1.81 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10,000 | -₹1.8 Cr | -₹1.54 Cr | -₹41.16 Lakh | -₹2.12 Cr | -₹35.99 Lakh | ₹81.98 Lakh | ₹1.81 Cr |
| Total Tax Expense | -₹93.95 Lakh | ₹0 | ₹0 | ₹45.66 Lakh | -₹47.34 Lakh | ₹19.07 Lakh | ₹22.85 Lakh | ₹47.24 Lakh |
| Net Profit | ₹94.05 Lakh | -₹1.8 Cr | -₹1.54 Cr | -₹86.82 Lakh | -₹1.64 Cr | -₹55.06 Lakh | ₹59.13 Lakh | ₹1.33 Cr |
| Other Comprehensive Income | ₹3.65 Lakh | ₹3.73 Lakh | ₹28,000 | -₹4.3 Lakh | ₹6.96 Lakh | ₹8.44 Lakh | ₹1.3 Lakh | ₹5.53 Lakh |
| Total Comprehensive Income | ₹97.7 Lakh | -₹1.76 Cr | -₹1.54 Cr | -₹91.12 Lakh | -₹1.57 Cr | -₹46.62 Lakh | ₹60.43 Lakh | ₹1.39 Cr |
| EBITDA (computed) | ₹12.75 Lakh | -₹1.68 Cr | -₹1.44 Cr | -₹29.43 Lakh | -₹2 Cr | -₹28.95 Lakh | ₹90.39 Lakh | ₹1.9 Cr |
| Basic EPS | ₹3.26 | ₹-5.87 | ₹-5.14 | ₹-3.04 | ₹-5.25 | ₹-1.55 | ₹2.01 | ₹4.63 |
| Diluted EPS | ₹3.26 | ₹-5.87 | ₹-5.14 | ₹-3.04 | ₹-5.25 | ₹-1.55 | ₹2.01 | ₹4.63 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹20.86 Cr | ₹20.49 Cr | ₹14.59 Cr | ₹14.53 Cr | ₹13.78 Cr | ₹13.87 Cr | ₹20.29 Cr | ₹22.52 Cr |
| Non-current Assets | ₹3.74 Cr | ₹2.99 Cr | ₹1.45 Cr | ₹1.13 Cr | ₹1.6 Cr | ₹1.15 Cr | ₹1.08 Cr | ₹76.74 Lakh |
| Current Assets | ₹17.12 Cr | ₹17.5 Cr | ₹13.14 Cr | ₹13.4 Cr | ₹12.19 Cr | ₹12.73 Cr | ₹19.21 Cr | ₹21.75 Cr |
| Property, Plant & Equipment | ₹36.46 Lakh | ₹46.04 Lakh | ₹33.34 Lakh | ₹37.25 Lakh | ₹38.59 Lakh | ₹14.23 Lakh | ₹17.58 Lakh | ₹19.17 Lakh |
| Inventories | ₹10.06 Cr | ₹10.47 Cr | ₹6.02 Cr | ₹4.79 Cr | ₹4.72 Cr | ₹25.68 Lakh | ₹38.89 Lakh | ₹33.86 Lakh |
| Trade Receivables | ₹3.55 Cr | ₹3.41 Cr | ₹3.88 Cr | ₹5.32 Cr | ₹2.81 Cr | ₹9.28 Cr | ₹15 Cr | ₹16.46 Cr |
| Cash & Equivalents | ₹28.06 Lakh | ₹19.95 Lakh | ₹39.73 Lakh | ₹43.88 Lakh | ₹22.46 Lakh | ₹39.63 Lakh | ₹39.99 Lakh | ₹54.47 Lakh |
| Equity (Net Worth) | ₹4.34 Cr | ₹3.36 Cr | ₹5.07 Cr | ₹6.31 Cr | ₹7.22 Cr | ₹8.8 Cr | ₹9.26 Cr | ₹8.66 Cr |
| Equity Share Capital | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹15.17 Cr | ₹9.33 Cr | ₹6.51 Cr | ₹8.05 Cr | ₹6.32 Cr | ₹4.9 Cr | ₹10.92 Cr | ₹13.7 Cr |
| Total Liabilities | ₹16.52 Cr | ₹17.13 Cr | ₹9.52 Cr | ₹8.22 Cr | ₹6.56 Cr | ₹5.08 Cr | ₹11.03 Cr | ₹13.86 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹11.19 Lakh | ₹4.75 Lakh | -₹2.34 Lakh | ₹30.16 Lakh | ₹18.78 Lakh |
| Investing Cash Flow | -₹2.62 Lakh | -₹24.16 Lakh | -₹1.21 Lakh | -₹9.56 Lakh | -₹29.7 Lakh |
| Financing Cash Flow | -₹45,000 | -₹37,000 | -₹37,900 | ₹82,000 | -₹6.25 Lakh |
| Capital Expenditure | ₹2.62 Lakh | ₹24.16 Lakh | ₹1.21 Lakh | ₹9.56 Lakh | ₹29.7 Lakh |
| Free Cash Flow (computed) | ₹8.57 Lakh | -₹19.41 Lakh | -₹3.55 Lakh | ₹20.6 Lakh | -₹10.92 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹8.12 Lakh | -₹19.78 Lakh | -₹3.93 Lakh | ₹21.42 Lakh | -₹17.16 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1.98 Cr | ₹4.31 Cr | ₹4.89 Cr | ₹5.8 Cr | ₹2.26 Cr | ₹3.84 Cr | ₹3.3 Cr | ₹4.06 Cr |
| Other Income | ₹18.09 Lakh | ₹9.1 Lakh | ₹9.12 Lakh | ₹9.09 Lakh | ₹9.12 Lakh | ₹8,000 | ₹13,000 | ₹0 |
| Total Income | ₹2.16 Cr | ₹4.4 Cr | ₹4.98 Cr | ₹5.89 Cr | ₹2.35 Cr | ₹3.85 Cr | ₹3.3 Cr | ₹4.06 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹1.3 Cr | ₹3.54 Cr | ₹5.36 Cr | ₹3.91 Cr | ₹3.18 Cr | ₹8 Cr | ₹2.45 Cr | ₹2.75 Cr |
| Changes in Inventories | ₹41.32 Lakh | ₹14.77 Lakh | -₹1.21 Cr | ₹1.05 Cr | -₹1.23 Cr | -₹4.54 Cr | ₹31.69 Lakh | ₹1.01 Cr |
| Employee Benefit Expense | ₹19.21 Lakh | ₹14.08 Lakh | ₹14.55 Lakh | ₹20.52 Lakh | ₹22.49 Lakh | ₹20.93 Lakh | ₹28.16 Lakh | ₹41.05 Lakh |
| Finance Costs | ₹23,000 | ₹1,000 | ₹3.1 Lakh | ₹3,000 | ₹21,000 | ₹1,000 | ₹15,000 | ₹0 |
| Depreciation & Amortisation | ₹3 Lakh | ₹3.03 Lakh | ₹18,000 | ₹3.07 Lakh | ₹3.13 Lakh | ₹3.08 Lakh | ₹2.71 Lakh | ₹2.54 Lakh |
| Other Expenses | ₹57.48 Lakh | ₹49.86 Lakh | ₹57.29 Lakh | ₹45.51 Lakh | ₹63.5 Lakh | ₹57.95 Lakh | ₹56.27 Lakh | ₹40.44 Lakh |
| Total Expenses | ₹2.51 Cr | ₹4.35 Cr | ₹4.91 Cr | ₹5.65 Cr | ₹2.84 Cr | ₹4.28 Cr | ₹3.64 Cr | ₹4.59 Cr |
| Profit Before Exceptional Items & Tax | -₹35.62 Lakh | ₹4.98 Lakh | ₹7.14 Lakh | ₹23.6 Lakh | -₹49.44 Lakh | -₹43.18 Lakh | -₹34.37 Lakh | -₹52.81 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹35.62 Lakh | ₹4.98 Lakh | ₹7.14 Lakh | ₹23.6 Lakh | -₹49.44 Lakh | -₹43.18 Lakh | -₹34.37 Lakh | -₹52.81 Lakh |
| Total Tax Expense | -₹93.95 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | ₹58.33 Lakh | ₹4.98 Lakh | ₹7.14 Lakh | ₹23.6 Lakh | -₹49.44 Lakh | -₹43.18 Lakh | -₹34.37 Lakh | -₹52.81 Lakh |
| Other Comprehensive Income | ₹8,000 | ₹2,000 | ₹35,000 | ₹3.2 Lakh | -₹8,000 | ₹6,000 | ₹5.71 Lakh | -₹1.97 Lakh |
| Total Comprehensive Income | ₹58.41 Lakh | ₹5 Lakh | ₹7.49 Lakh | ₹26.8 Lakh | -₹49.52 Lakh | -₹43.12 Lakh | -₹28.66 Lakh | -₹54.78 Lakh |
| EBITDA (computed) | -₹32.39 Lakh | ₹8.02 Lakh | ₹10.42 Lakh | ₹26.7 Lakh | -₹46.1 Lakh | -₹40.09 Lakh | -₹31.51 Lakh | -₹50.27 Lakh |
| Basic EPS | ₹1.95 | ₹0.17 | ₹0.25 | ₹0.89 | ₹-1.65 | ₹-1.44 | ₹-0.96 | ₹-1.83 |
| Diluted EPS | ₹1.95 | ₹0.17 | ₹0.25 | ₹0.89 | ₹-1.65 | ₹-1.44 | ₹-0.96 | ₹-1.83 |
Shareholding Pattern of Brawn Biotech Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 52.94%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.35%, retail and other public shareholders hold 46.71% of Brawn Biotech Limited. The company had 3,303 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 52.94% | 53.39% | 53.66% | 53.66% | 53.66% | 53.64% |
| Public | 47.06% | 46.61% | 46.34% | 46.34% | 46.34% | 46.36% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 52.94% | 53.66% | 53.64% |
| Public | 47.06% | 46.34% | 46.36% |
| Promoter change (YoY, %pts) | -0.72 | +0.02 | - |
Charges & Borrowings of Brawn Biotech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Apr 2015 | Punjab National Bank | ₹6.74 Lakh | Satisfied |
| 21 Apr 2015 | Punjab National Bank | ₹6.74 Lakh | Satisfied |
| 09 Apr 2014 | Punjab National Bank | ₹14.6 Lakh | Satisfied |
| 01 Sep 2011 | Punjab National Bank | ₹2.2 Lakh | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Brawn Biotech Limited
View historical data on people associated with Brawn Biotech Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Brawn Biotech Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Brawn Biotech Limited
GSTIN & GST Filing Data of Brawn Biotech Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Brawn Biotech Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Brawn Biotech Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Brawn Biotech Limited
MSME Payment Delays by Brawn Biotech Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Brawn Biotech Limited
Subsidiaries & Group Companies of Brawn Biotech Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Brawn Biotech Limited with ownership details.
MCA Filings & Documents of Brawn Biotech Limited
MCA Filings & Documents of Brawn Biotech Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Brawn Biotech Limited
Frequently Asked Questions about Brawn Biotech Limited
Brawn Biotech Limited is an active public limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 07 November 1985 (41+ years old) and is registered under CIN L74899DL1985PLC022468. Listed on BSE: 530207.
Brawn Biotech Limited reported revenue of ₹13.56 Cr for FY 2025 (down 18.00% YoY).
The current directors of Brawn Biotech Limited are:
- Brij Raj Gupta
- Brij Bala Gupta
- Pooja Pandey
- Mayank Jain
- Priyanka Sharma
- Pooja Jha
The primary industry of Brawn Biotech Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Yes. Brawn Biotech Limited is listed on BSE with code 530207.
Brawn Biotech Limited can be reached at the registered office: First Floor C – 64 Lagpat Nagar – 1, Delhi, Delhi, India – 110024, or through the website brawnbiotech.com.